Food amyloid fibrils are safe nutrition ingredients based on in-vitro and in-vivo assessment
Dan Xu,Jiangtao Zhou,Wei Long Soon,Ines Kutzli,Adrian Molière,Sabine Diedrich,Milad Radiom,Stephan Handschin,Bing Li,Lin Li,Shana J Sturla,Collin Y Ewald,Raffaele Mezzenga
DOI: https://doi.org/10.1038/s41467-023-42486-x
2023-10-26
Abstract:Food protein amyloid fibrils have superior technological, nutritional, sensorial, and physical properties compared to native monomers, but there is as yet insufficient understanding of their digestive fate and safety for wide consumption. By combining SDS-PAGE, ELISA, fluorescence, AFM, MALDI-MS, CD, microfluidics, and SAXS techniques for the characterization of β-lactoglobulin and lysozyme amyloid fibrils subjected to in-vitro gastrointestinal digestion, here we show that either no noticeable conformational differences exist between amyloid aggregates and their monomer counterparts after the gastrointestinal digestion process (as in β-lactoglobulin), or that amyloid fibrils are digested significantly better than monomers (as in lysozyme). Moreover, in-vitro exposure of human cell lines and in-vivo studies with C. elegans and mouse models, indicate that the digested fibrils present no observable cytotoxicity, physiological abnormalities in health-span, nor accumulation of fibril-induced plaques in brain nor other organs. These extensive in-vitro and in-vivo studies together suggest that the digested food amyloids are at least equally as safe as those obtained from the digestion of corresponding native monomers, pointing to food amyloid fibrils as potential ingredients for human nutrition.